D
Dieter Buchheidt
Researcher at University Hospital Heidelberg
Publications - 158
Citations - 7867
Dieter Buchheidt is an academic researcher from University Hospital Heidelberg. The author has contributed to research in topics: Aspergillosis & Neutropenia. The author has an hindex of 50, co-authored 158 publications receiving 6777 citations. Previous affiliations of Dieter Buchheidt include University of Mannheim & Heidelberg University.
Papers
More filters
Journal ArticleDOI
Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline
Andrew J. Ullmann,José María Aguado,S. Arikan-Akdagli,David W. Denning,Andreas H. Groll,Katrien Lagrou,Cornelia Lass-Flörl,Russell E. Lewis,Patricia Muñoz,Paul E. Verweij,Adilia Warris,Florence Ader,Florence Ader,Murat Akova,Maiken Cavling Arendrup,Rosemary Ann Barnes,Catherine Beigelman-Aubry,Catherine Beigelman-Aubry,Stijn Blot,Stijn Blot,Stijn Blot,Emilio Bouza,Roger J. M. Brüggemann,Dieter Buchheidt,Jacques Cadranel,Jacques Cadranel,Elio Castagnola,Arunaloke Chakrabarti,Manuel Cuenca-Estrella,George Dimopoulos,George Dimopoulos,Jesús Fortún,Jean-Pierre Gangneux,Jorge Garbino,Werner J. Heinz,Raoul Herbrecht,Claus Peter Heussel,Christopher C. Kibbler,Nikolay Klimko,Bart Jan Kullberg,Christoph Lange,Thomas Lehrnbecher,Jürgen Löffler,Olivier Lortholary,J Maertens,O. Marchetti,Jacques F. Meis,Livio Pagano,Patricia Ribaud,Malcolm Richardson,Emmanuel Roilides,Markus Ruhnke,Maurizio Sanguinetti,Donald C. Sheppard,János Sinkó,Anna Skiada,Maria J G T Vehreschild,Claudio Viscoli,Oliver A. Cornely +58 more
TL;DR: Treatment duration for aspergillosis is strongly recommended based on clinical improvement, degree of immunosuppression and response on imaging, and in refractory disease, where a personalized approach considering reversal of predisposing factors, switching drug class and surgical intervention is also strongly recommended.
Journal ArticleDOI
Treatment of invasive fungal infections in cancer patients-updated recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)
Sabine Mousset,Dieter Buchheidt,Werner J. Heinz,Markus Ruhnke,Oliver A. Cornely,Gerlinde Egerer,William Krüger,Hartmut Link,Silke Neumann,Helmut Ostermann,Jens Panse,Olaf Penack,Christina Rieger,Martin Schmidt-Hieber,Gerda Silling,Thomas Südhoff,Andrew J. Ullmann,Hans-Heinrich Wolf,Georg Maschmeyer,Angelika Böhme +19 more
TL;DR: The Infectious Diseases Working Party of the German Society of Hematology and Oncology here presents its 2008 recommendations discussing the dos and do-nots, as well as the problems and possible solutions, of evidence criteria selection.
Journal ArticleDOI
Specific Detection of Aspergillus Species in Blood and Bronchoalveolar Lavage Samples of Immunocompromised Patients by Two-Step PCR
H. Skladny,Dieter Buchheidt,Corinna Baust,F. Krieg-Schneider,Wolfgang Seifarth,Christine Leib-Mösch,Rüdiger Hehlmann +6 more
TL;DR: A two-step PCR assay that specifically amplifies a region of the 18S rRNA gene that is highly conserved in Aspergillus species is developed that allows direct and rapid detection of down to 10 fg of AsPergillus DNA corresponding to 1 to 5 CFU per ml of blood.
Journal ArticleDOI
Performance of Galactomannan, Beta-d-Glucan, Aspergillus Lateral-Flow Device, Conventional Culture, and PCR Tests with Bronchoalveolar Lavage Fluid for Diagnosis of Invasive Pulmonary Aspergillosis
Martin Hoenigl,Juergen Prattes,Bruce D. Spiess,Jasmin Wagner,Florian Prueller,Reinhard B. Raggam,V. Posch,Wiebke Duettmann,K. Hoenigl,Albert Wölfler,Christoph Koidl,Walter Buzina,Mark Reinwald,Christopher R. Thornton,Robert Krause,Dieter Buchheidt +15 more
TL;DR: Established and novel diagnostic methods for IPA are evaluated and it is found that the Aspergillus PCR, LFD, and GM tests were the most useful methods for diagnosing the disease by using BAL fluid samples.
Journal ArticleDOI
Primary prophylaxis of invasive fungal infections in patients with hematologic malignancies. Recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology
Oliver A. Cornely,Angelika Böhme,Dieter Buchheidt,Hermann Einsele,Werner J. Heinz,Meinolf Karthaus,Stefan W. Krause,William Krüger,Georg Maschmeyer,Olaf Penack,Jörg Ritter,Markus Ruhnke,Michael Sandherr,Michal Sieniawski,Jorg-Janne Vehreschild,Hans-Heinrich Wolf,Andrew J. Ullmann +16 more
TL;DR: Aerosolized liposomal amphotericin B is recommended during prolonged neutropenia and Posaconazole 600 mg/d is recommended in patients with acute myelogenous leukemia/myelodysplastic syndrome or undergoing allogeneic stem cell recipients with graft versus host disease for the prevention of invasive fungal infections and attributable mortality.